__NUXT_JSONP__("/drugs/HER2-targeting_Antibody_Fc_Fragment_FS102", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A proprietary, antibody fragment composed of a constant (Fc) region that is engineered to bind to the tumor-associated antigen human epidermal growth factor receptor-2 (HER2), with potential antineoplastic activity. HER2-targeted antibody Fc fragment FS102 specifically binds to its HER2 epitope, and causes downregulation of HER2-mediated signaling. This leads to tumor cell apoptosis. HER2, a member of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (EGFR) superfamily, is overexpressed on the cell surface of various solid tumors.",fdaUniiCode:"Z27ZI1MZY9",identifier:"C118953",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129820","C129821"],synonyms:["Anti-HER2 FCAB FS102","BMS-986186","FS-102","FS102","Fcab FS102",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FHER2-targeting_Antibody_Fc_Fragment_FS102",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","HER2-targeting_Antibody_Fc_Fragment_FS102","HER2-targeting Antibody Fc Fragment FS102","2021-10-30T13:19:48.603Z")));